INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 446m ago
HOUSE PTR45m ago
SEC 13F45m ago
ROBINHOOD CHAIN45m ago
Public company

AtriCure, Inc.

ATRCCIK 0001323885

EDGAR filingsOpen in network
Price$58.54
1 year+81.1%
Disclosed transactions7
Buys / sells2 / 3
Max Insider Score31
Connections with evidence8

ATRC · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
PS
Privitera SalvatoreChief Technical Officer
ATRCAtriCure, Inc.
Open-market sale · 10b5-1 plan
SELL$546K
8,404 sh
Nov 4, 2026Nov 5, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Privitera SalvatoreOfficer · Form 144 · Nov 3, 2026
  • ← Holds over 5% ofevidence
    Vanguard Portfolio Management7.22% of class · Schedule 13G · Oct 29, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-10 · Sep 10, 2026
  • ← Lobbied forevidence
traded Nov 4, 2026
+1d
SEC FORM 4

Evidence

27
Gilbert Ray Cisneros, Jr.DSelf
ATRCAtriCure, Inc.
Partial sale
SELL$1,001 – $15KSep 29, 2026Oct 12, 2026
traded Sep 29, 2026
+13dHOUSE PTR

Evidence

20
Gilbert Ray Cisneros, Jr.DSelf
ATRCAtriCure, Inc.
Purchase
BUY$1,001 – $15KAug 20, 2026Sep 10, 2026
traded Aug 20, 2026
+21dHOUSE PTR

Evidence

31
DS
Dahlquist Karl S.Chief Legal Officer
ATRCAtriCure, Inc.
Open-market sale
SELL$458K
9,370 sh
Aug 24, 2026Aug 26, 2026
traded Aug 24, 2026
+2dSEC FORM 4

Evidence

17
TH
Telman Deborah HDirector
ATRCAtriCure, Inc.
Grant or award
A—
6,144 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

17
NS
Nachman ShlomoDirector
ATRCAtriCure, Inc.
Grant or award
A—
6,144 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC FORM 4

Evidence

28
Gilbert Ray Cisneros, Jr.DSelf
ATRCAtriCure, Inc.
Purchase
BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
traded Mar 3, 2026
+35dHOUSE PTR

Evidence

FOLEY HOAG LLP
LDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Dahlquist Karl S.Chief Legal Officer · Aug 26, 2026
  • ← Insider ofevidence
    Telman Deborah HDirector · May 20, 2026
  • ← Insider ofevidence
    Nachman ShlomoDirector · May 20, 2026

    • Lobbying

    $50K reported · de-duplicated
    2026 Q3 $10K via firms2026 Q2 $20K via firms2026 Q1 $20K via firms
    • FOLEY HOAG LLP$10K2026 Q3 · posted Aug 26, 2026 · Medicare/Medicaid
    • FOLEY HOAG LLP$20K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • FOLEY HOAG LLP$20K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.

    Planned sales and 5% stakes

    Form 144, 13D and 13G
    • SPSALVATORE PRIVITERAOfficer · sale around Nov 4, 2026 · 8,404 shares · 10b5-1 plan$546KForm 144 · filed Nov 4, 2026
    • VMVanguard Portfolio ManagementPassive holder · crossed on Sep 30, 2026 · 3.68M shares7.22% of class13G amendment · filed Oct 30, 2026